Primary sclerosing cholangitis: The emerging role for liver transplantation

A. N. Langnas, G. L. Grazi, R. J. Stratta, R. P. Wood, W. Marujo, R. S. Markin, J. Donovan, D. Burnett, R. Zetterman, M. Sorrell, B. W. Shaw

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Primary sclerosing cholangitis is a progressive liver disease for which orthotopic liver transplantation is the only curative procedure. Questions exist regarding the role of temporizing procedures and the timing of transplantation. During the past 4 yr, we have performed liver transplants in 177 adult recipients. Twenty-six patients (14.6%) with primary sclerosing cholangitis received 30 transplants including 12 men and 14 women. The recipients were examined for a number of preoperative and postoperative variables. The 4-yr actuarial survival in patients with primary sclerosing cholangitis after transplantation was 88%. Patients were segregated according to preoperative risk variables. Twenty patients were low and medium risk, with one death (95% survival). Three patients were high risk, with two deaths (33% survival). In conclusion, orthotopic liver transplantation is safe and effective therapy for primary sclerosing cholangitis. Early referral for transplantation is recommended to reduce the mortality associated with this procedure in those with advanced hepatic failure.

Original languageEnglish
Pages (from-to)1136-1141
Number of pages6
JournalAmerican Journal of Gastroenterology
Volume85
Issue number9
Publication statusPublished - 1990

Fingerprint

Sclerosing Cholangitis
Liver Transplantation
Transplantation
Survival
Transplants
Liver Failure
Liver Diseases
Referral and Consultation
Mortality
Liver

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Langnas, A. N., Grazi, G. L., Stratta, R. J., Wood, R. P., Marujo, W., Markin, R. S., ... Shaw, B. W. (1990). Primary sclerosing cholangitis: The emerging role for liver transplantation. American Journal of Gastroenterology, 85(9), 1136-1141.

Primary sclerosing cholangitis : The emerging role for liver transplantation. / Langnas, A. N.; Grazi, G. L.; Stratta, R. J.; Wood, R. P.; Marujo, W.; Markin, R. S.; Donovan, J.; Burnett, D.; Zetterman, R.; Sorrell, M.; Shaw, B. W.

In: American Journal of Gastroenterology, Vol. 85, No. 9, 1990, p. 1136-1141.

Research output: Contribution to journalArticle

Langnas, AN, Grazi, GL, Stratta, RJ, Wood, RP, Marujo, W, Markin, RS, Donovan, J, Burnett, D, Zetterman, R, Sorrell, M & Shaw, BW 1990, 'Primary sclerosing cholangitis: The emerging role for liver transplantation', American Journal of Gastroenterology, vol. 85, no. 9, pp. 1136-1141.
Langnas AN, Grazi GL, Stratta RJ, Wood RP, Marujo W, Markin RS et al. Primary sclerosing cholangitis: The emerging role for liver transplantation. American Journal of Gastroenterology. 1990;85(9):1136-1141.
Langnas, A. N. ; Grazi, G. L. ; Stratta, R. J. ; Wood, R. P. ; Marujo, W. ; Markin, R. S. ; Donovan, J. ; Burnett, D. ; Zetterman, R. ; Sorrell, M. ; Shaw, B. W. / Primary sclerosing cholangitis : The emerging role for liver transplantation. In: American Journal of Gastroenterology. 1990 ; Vol. 85, No. 9. pp. 1136-1141.
@article{d47607361b4a46439db37653158a8f36,
title = "Primary sclerosing cholangitis: The emerging role for liver transplantation",
abstract = "Primary sclerosing cholangitis is a progressive liver disease for which orthotopic liver transplantation is the only curative procedure. Questions exist regarding the role of temporizing procedures and the timing of transplantation. During the past 4 yr, we have performed liver transplants in 177 adult recipients. Twenty-six patients (14.6{\%}) with primary sclerosing cholangitis received 30 transplants including 12 men and 14 women. The recipients were examined for a number of preoperative and postoperative variables. The 4-yr actuarial survival in patients with primary sclerosing cholangitis after transplantation was 88{\%}. Patients were segregated according to preoperative risk variables. Twenty patients were low and medium risk, with one death (95{\%} survival). Three patients were high risk, with two deaths (33{\%} survival). In conclusion, orthotopic liver transplantation is safe and effective therapy for primary sclerosing cholangitis. Early referral for transplantation is recommended to reduce the mortality associated with this procedure in those with advanced hepatic failure.",
author = "Langnas, {A. N.} and Grazi, {G. L.} and Stratta, {R. J.} and Wood, {R. P.} and W. Marujo and Markin, {R. S.} and J. Donovan and D. Burnett and R. Zetterman and M. Sorrell and Shaw, {B. W.}",
year = "1990",
language = "English",
volume = "85",
pages = "1136--1141",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Primary sclerosing cholangitis

T2 - The emerging role for liver transplantation

AU - Langnas, A. N.

AU - Grazi, G. L.

AU - Stratta, R. J.

AU - Wood, R. P.

AU - Marujo, W.

AU - Markin, R. S.

AU - Donovan, J.

AU - Burnett, D.

AU - Zetterman, R.

AU - Sorrell, M.

AU - Shaw, B. W.

PY - 1990

Y1 - 1990

N2 - Primary sclerosing cholangitis is a progressive liver disease for which orthotopic liver transplantation is the only curative procedure. Questions exist regarding the role of temporizing procedures and the timing of transplantation. During the past 4 yr, we have performed liver transplants in 177 adult recipients. Twenty-six patients (14.6%) with primary sclerosing cholangitis received 30 transplants including 12 men and 14 women. The recipients were examined for a number of preoperative and postoperative variables. The 4-yr actuarial survival in patients with primary sclerosing cholangitis after transplantation was 88%. Patients were segregated according to preoperative risk variables. Twenty patients were low and medium risk, with one death (95% survival). Three patients were high risk, with two deaths (33% survival). In conclusion, orthotopic liver transplantation is safe and effective therapy for primary sclerosing cholangitis. Early referral for transplantation is recommended to reduce the mortality associated with this procedure in those with advanced hepatic failure.

AB - Primary sclerosing cholangitis is a progressive liver disease for which orthotopic liver transplantation is the only curative procedure. Questions exist regarding the role of temporizing procedures and the timing of transplantation. During the past 4 yr, we have performed liver transplants in 177 adult recipients. Twenty-six patients (14.6%) with primary sclerosing cholangitis received 30 transplants including 12 men and 14 women. The recipients were examined for a number of preoperative and postoperative variables. The 4-yr actuarial survival in patients with primary sclerosing cholangitis after transplantation was 88%. Patients were segregated according to preoperative risk variables. Twenty patients were low and medium risk, with one death (95% survival). Three patients were high risk, with two deaths (33% survival). In conclusion, orthotopic liver transplantation is safe and effective therapy for primary sclerosing cholangitis. Early referral for transplantation is recommended to reduce the mortality associated with this procedure in those with advanced hepatic failure.

UR - http://www.scopus.com/inward/record.url?scp=0025154889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025154889&partnerID=8YFLogxK

M3 - Article

C2 - 2167607

AN - SCOPUS:0025154889

VL - 85

SP - 1136

EP - 1141

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 9

ER -